Indian Journal of Medical Microbiology

Journal Information
ISSN / EISSN : 0255-0857 / 1998-3646
Published by: Elsevier BV (10.1016)
Total articles ≅ 3,036
Current Coverage
SCOPUS
SCIE
LOCKSS
MEDICUS
MEDLINE
PUBMED
DOAJ
Archived in
EBSCO
SHERPA/ROMEO
Filter:

Latest articles in this journal

Pooja Thakkar, , Sweta Shah, Rohit Bhavsar, Shweta Ladi, Roshan Elizabeth John, Rubina Chavan, Reshma Naik
Published: 22 September 2021
Indian Journal of Medical Microbiology; https://doi.org/10.1016/j.ijmmb.2021.09.005

Abstract:
Antimicrobial resistance has emerged as a major public health problem in India. Hence effective antimicrobial stewardship programs (AMSP) are needed. We report the design, implementation and results of a prospective audit and feedback based AMSP at a private tertiary care hospital.
Mingming Zhou, Pan Fu, Chao Fang, , , Chunmei Jing, Hongmei Xu, Yunsheng Chen, Jikui Deng, Hong Zhang, et al.
Published: 21 September 2021
Indian Journal of Medical Microbiology; https://doi.org/10.1016/j.ijmmb.2021.09.001

Abstract:
This study set out to determine the antimicrobial resistance trends of Haemophilus influenzae isolates from pediatric hospitals in Mainland China, which would provide basis for clinical treatment.
Sukriti Sabharwal, Sanghamitra Datta, , Anil Sachdeva
Published: 21 September 2021
Indian Journal of Medical Microbiology; https://doi.org/10.1016/j.ijmmb.2021.09.003

Abstract:
To find out the prevalence of respiratory viruses causing Acute Respiratory Infection in pediatric in-patients during Pre-COVID times.
Published: 10 September 2021
Indian Journal of Medical Microbiology; https://doi.org/10.1016/j.ijmmb.2021.08.458

Abstract:
This paper explores inclusion of topics on antimicrobial resistance (AMR) and antimicrobial stewardship (AMS) in pre-service human and animal healthcare professional curricula as mandated in the first strategic objective of National Action Plan on Antimicrobial Resistance.
Chun-Quan Xu, Xiu-Cai Zhang, Qing Wu, Li-Jiang Chen, Ping-Hua Qu, Yi-Zhi Zhang, ,
Published: 4 September 2021
Indian Journal of Medical Microbiology; https://doi.org/10.1016/j.ijmmb.2021.08.002

Abstract:
Cysteiniphilum litorale is a Gram-negative coccobacillus first isolated from the seawater of Wailingding Island near the estuary of Pearl River in southern China. This organism was previously not considered to cause disease in animals or humans. We report a case of a 19-year-old female patient infected with abscess caused by C. litorale in the middle digit of her right hand after minor trauma during the handling of estuarine shrimps at home. C. litorale was cultured from the wound exudate of the patient and identified by 16S rRNA gene sequencing. Whether C. litorale may be transmitted to humans via other channels requires further exploration.
Published: 1 September 2021
Indian Journal of Medical Microbiology; https://doi.org/10.1016/j.ijmmb.2021.08.004

Abstract:
Prevention of healthcare-associated infections (HAI) like ventilator associated pneumonia (VAP) is particularly challenging especially in resource limited settings. Complex microbial interactions between patients and health care workers (HCWs) further complicate the situation, requiring a holistic approach for successful management. To bridge the gap between laboratory and intensive care unit (ICU) this study was conducted to find the role of hand-held microscope ‘Foldscope’ in restricting empirical therapy in intubated patients.
Tasneem Siddiqui, , Sangram Singh Patel
Published: 1 September 2021
Indian Journal of Medical Microbiology; https://doi.org/10.1016/j.ijmmb.2021.08.003

Abstract:
Ceftaroline is a novel antibiotic approved by USA Food and Drug Administration (FDA) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP). It has potent in vitro activity against Staphylococci, including methicillin-resistant strains, whose incidence is increasing worldwide and they are often difficult to treat. The present study was done to investigate the susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative Staphylococcus (MR-CoNS) to ceftaroline and other antimicrobial agents in patient samples and to evaluate clinical profile of these patients.
Back to Top Top